Recent findings in MGUS
Speaker(s)
Prof. Sigurdur Kristinsson
Monoclonal gammopathy of undetermined significance, called MGUS, is a blood condition which indicates occurrence of clonal cells that secrete monoclonal immunoglobulins. MGUS as such, is not a harmful disease, and usually doesn’t require treatment. However, every year 1 percent of MGUS patients go on to develop myeloma or lymphoma.
In this episode we have the pleasure of having the Icelandic Professor Sigurdur Kristinsson with us. He specialises in internal medicine and hematology. He has led several large population-based myeloma studies in collaboration with major research centers and is a frequent speaker at international hematology conferences. Professor Kristinsson will bring us up to date on recent understandings of the MGUS condition, what symptoms we as health care professionals should be aware of and how to diagnose today – and what could be possible in the future.
MAT-BE-2300364 (Ver. 1.0) 04 2023
Also interesting...
Liquid biopsy, MRD, Multiple Myeloma
Measurable Residual Disease and Decision-Making in Multiple Myeloma
Immuno oncology, Multiple Myeloma
Hypogammaglobulinemia newsletter
EMD, MGUS, Multiple Myeloma
Smoldering Multiple Myeloma – to treat or not to treat?
Hematologists, Hematology, MGUS, Multiple Myeloma
MGRS- Monoclonal Gammopathy of Renal Significance
MGUS